JPRN-UMIN000052208尚未招募Unknown
Prospective observational study on prevention methods and causes of vasculitis and vascular pain caused by vinorelbine - Prospective observational study on prevention methods and causes of vasculitis and vascular pain caused by vinorelbine
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Prospective observation group: 1) Used for treatments other than cisplatin + vinorelbine combination therapy for lung cancer Patients on regimens containing vinorelbine 2) Patients with heart failure 3) Patients with poor renal function Retrospective observation group: 1) Used for treatments other than cisplatin + vinorelbine combination therapy for lung cancer Patients on regimens containing vinorelbine 2) Patients with a history of heart failure 3) Patients with poor renal function 4) This treatment is performed on the 1st day and the 8th day, but patients who complete the treatment without performing the treatment on the 8th day
研究者
相似试验
招募中
不适用
Prospective study for Investigation and prevention for HBV reactivatioJPRN-UMIN000009491Department of Hepatology, Osaka City University Graduate School of Medicine500
招募中
不适用
prospective intervention study of prevention of infections by chlorhexidine-impregnated sponge dressings for patients with tunneled central venous catheterspatients with pulmonary arterial hypertensionJPRN-UMIN000005438Department of cardiology, Keio University School of Medicine30
招募中
不适用
A prospective study to confirm the effect of preventive lymph node venous anastomosis in gynecological cancer surgeryKCT0007748Asan Medical Center50
已完成
不适用
Prospective randomized controlled study for preventive effect of menatetrenone against the recurrence of hepatocellular carcinoma after hepatectomyHepatocellular carcinomaJPRN-UMIN000001815Second Department of Surgery Dokkyo Medical University84
已完成
不适用
Additional prospective study for the prevention of diabetic macrovascular complications.Type 2 DiabetesJPRN-UMIN000006675MSDM(Additional prospective study)500